Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2

Conditions

Myelodysplastic Syndromes 120Leukemia, Myeloid, Acute 106Precursor Cell Lymphoblastic Leukemia-Lymphoma 92Hodgkin Disease 70Leukemia 67Leukemia, Lymphocytic, Chronic, B-Cell 65Lymphoma, Non-Hodgkin 63Multiple Myeloma 59Myeloproliferative Disorders 57Lymphoma 54Leukemia, Myelogenous, Chronic, BCR-ABL Positive 47Leukemia, Myeloid, Accelerated Phase 46Lymphoma, Follicular 44Leukemia, Myelomonocytic, Chronic 44Leukemia, Myeloid, Chronic-Phase 44Congenital Abnormalities 43Lymphoma, Mantle-Cell 42Primary Myelofibrosis 41Lymphoma, Large B-Cell, Diffuse 41Lymphoma, B-Cell, Marginal Zone 39Burkitt Lymphoma 36Blast Crisis 36Graft vs Host Disease 35Neoplasms, Plasma Cell 34Lymphoma, Large-Cell, Immunoblastic 32Myelodysplastic-Myeloproliferative Diseases 25Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 25Waldenstrom Macroglobulinemia 21Lymphoma, T-Cell, Cutaneous 20Anemia, Refractory, with Excess of Blasts 20

Interventions

fludarabine 2Tacrolimus 2fludarabine phosphate 1Whole-Body Irradiation 1Stem Cell Transplantation 1Mycophenolic Acid 1Cyclophosphamide 1Busulfan 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Paraproteinemias × Tacrolimus × Myeloid × Clear all
NCT02556931 2022-11-03

Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
117 enrolled 27 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Paraproteinemias, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myelomonocytic, Chronic, Neoplasms, Plasma Cell, Primary Myelofibrosis

NCT00579111 2016-05-04

Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

Baylor College of Medicine

Phase 1/2 Terminated
4 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hematologic Diseases, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Paraproteinemias, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡